Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-03 · accession 0000899243-22-035311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-07 | 2022-11-03+ | ANTX | Easom Eric | CEO, Dir | S - Sale | $15.86 | -35.2K | 6,943 | -84% | -$558.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-03 | S | D | 11,082 | $15.67 | 29,021 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-07 | S | D | 2,036 | $16.72 | 4,907 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-03 | S | D | 3,083 | $16.02 | 25,938 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-04 | S | D | 8,828 | $15.80 | 17,110 | D | — | — | |
| 5 | Common | Common Stock | 2022-11-07 | S | D | 10,167 | $15.90 | 6,943 | D | — | — |